The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing
Open accessAbstract
Background: Estimating the prevalence of autosomal dominant polycystic kidney disease (ADPKD) is challenging because of age-dependent penetrance and incomplete clinical ascertainment. Early studies estimated the lifetime risk of ADPKD to be about one per 1000 in the general population, whereas recent epidemiologic studies report a point prevalence of three to five cases per 10,000 in the general population. Methods: To measure the frequency of high-confidence mutations presumed to be causative in ADPKD and autosomal dominant polycystic liver disease (ADPLD) and estimate lifetime ADPKD prevalence, we used two large, population sequencing databases, gnomAD (15,496 whole-genome sequences; 123,136 exome sequences) and BRAVO (62,784 whole-genome sequences). We used stringent criteria for defining rare variants in genes involved in ADPKD (PKD1, PKD2), ADPLD (PRKCSH, SEC63, GANAB, ALG8, SEC61B, LRP5), and potential cystic disease modifiers; evaluated variants for quality and annotation; compared variants with data from an ADPKD mutation database; and used bioinformatic tools to predict pathogenicity. Results: Identification of high-confidence pathogenic mutations in whole-genome sequencing provided a lower boundary for lifetime ADPKD prevalence of 9.3 cases per 10,000 sequenced. Estimates from whole-genome and exome data were similar. Truncating mutations in ADPLD genes and genes of potential relevance as cyst modifiers were found in 20.2 cases and 103.9 cases per 10,000 sequenced, respectively. Conclusions: Population whole-genome sequencing suggests a higher than expected prevalence of ADPKD-associated mutations. Loss-of-function mutations in ADPLD genes are also more common than expected, suggesting the possibility of unrecognized cases and incomplete penetrance. Substantial rare variation exists in genes with potential for phenotype modification in ADPKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Genetic effects on gene expression across human tissues
GTEx Consortium (2017) · Nature · doi:10.1038/nature24277 · Cited by 4,036
Northrup, H., Krueger, D. A., Northrup, H., Krueger, D. A., Roberds, S., Smith, K., Sampson, J., Korf, B., Kwiatkowski, D. J., Mowat, D., et al. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.08.001 · Cited by 1,502
Walsh, R., Thomson, K. L., Ware, J. S., Funke, B. H., Woodley, J., McGuire, K. J., Mazzarotto, F., Blair, E., Seller, A., Taylor, J. C., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.90 · Cited by 734
Dalgaard, O. Z. (1957) · PubMed · Cited by 426
Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases
Cornec-Le Gall, E., Torres, V. E., & Harris, P. C. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017050483 · Cited by 406
Self-citationEpidemiology of Adult Polycystic Kidney Disease, Olmsted County, Minnesota: 1935–1980
Garcia Iglesias, C., Torres, V. E., Offord, K. P., Holley, K. E., Beard, C. M., & Kurland, L. T. (1983) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(83)80044-4 · Cited by 384
Harris, P. C., Bae, K. T., Rossetti, S., Torres, V. E., Grantham, J. J., Chapman, A. B., Guay-Woodford, L. M., King, B. F., Wetzel, L. H., Baumgarten, D. A., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080835 · Cited by 271
Self-citationPrevalence of autosomal dominant polycystic kidney disease in the European Union
Willey, C. J., Blais, J. D., Hall, A. K., Krasa, H. B., Makin, A. J., & Czerwiec, F. S. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw240 · Cited by 249
Mutations in Multiple PKD Genes May Explain Early and Severe Polycystic Kidney Disease
Bergmann, C., von Bothmer, J., Ortiz Brüchle, N., Venghaus, A., Frank, V., Fehrenbach, H., Hampel, T., Pape, L., Buske, A., Jonsson, J., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010101080 · Cited by 238
Clinical profile of autosomal dominant polycystic liver disease
Qian, Q., Li, A., King, B. F., Kamath, P. S., Lager, D. J., Huston, J., Shub, C., Davila, S., Somlo, S., & Torres, V. E. (2003) · Hepatology · doi:10.1053/jhep.2003.50006 · Cited by 236
Kobayashi, Y., Yang, S., Nykamp, K., Garcia, J., Lincoln, S. E., & Topper, S. E. (2017) · Genome Medicine · doi:10.1186/s13073-017-0403-7 · Cited by 232
Isolated polycystic liver disease genes define effectors of polycystin-1 function
Besse, W., Dong, K., Choi, J., Punia, S., Fedeles, S. V., Choi, M., Gallagher, A.-R., Huang, E. B., Gulati, A., Knight, J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90129 · Cited by 203
Self-citationEvaluation of hepatic cystic lesions
Lantinga, M. A. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i23.3543 · Cited by 198
Heyer, C. M., Sundsbak, J. L., Abebe, K. Z., Chapman, A. B., Torres, V. E., Grantham, J. J., Bae, K. T., Schrier, R. W., Perrone, R. D., Braun, W. E., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050583 · Cited by 190
Self-citationBILATERAL POLYCYSTIC DISEASE OF THE KIDNEYS
DALGAARD, O. Z. (1959) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195904000-00016 · Cited by 181
Douville, C. B., Masica, D. L., Stenson, P. D., Cooper, D. N., Gygax, D. M., Kim, R., Ryan, M., & Karchin, R. (2015) · Human Mutation · doi:10.1002/humu.22911 · Cited by 163
Bilineal Disease and Trans-Heterozygotes in Autosomal Dominant Polycystic Kidney Disease
Pei, Y., Paterson, A. D., Wang, K. R., He, N., Hefferton, D., Watnick, T., Germino, G. G., Parfrey, P., Somlo, S., & St. George-Hyslop, P. (2001) · The American Journal of Human Genetics · doi:10.1086/318188 · Cited by 163
Self-citationRefining Genotype-Phenotype Correlation in Autosomal Dominant Polycystic Kidney Disease
Hwang, Y.-H., Conklin, J., Chan, W., Roslin, N. M., Liu, J., He, N., Wang, K., Sundsbak, J. L., Heyer, C. M., Haider, M., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015060648 · Cited by 160
Self-citationAltered trafficking and stability of polycystins underlie polycystic kidney disease
Cai, Y., Fedeles, S. V., Dong, K., Anyatonwu, G., Onoe, T., Mitobe, M., Gao, J.-D., Okuhara, D., Tian, X., Gallagher, A.-R., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67273 · Cited by 158
Hepatocyte Nuclear Factor 1β–Associated Kidney Disease: More than Renal Cysts and Diabetes
Verhave, J. C., Bech, A. P., Wetzels, J. F. M., & Nijenhuis, T. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050544 · Cited by 158
Earle, D. P. (1958) · Archives of Internal Medicine · doi:10.1001/archinte.1958.00260200160014 · Cited by 154
Van Keimpema, L., De Koning, D. B., Van Hoek, B., Van Den Berg, A. P., Van Oijen, M. G. H., De Man, R. A., Nevens, F., & Drenth, J. P. H. (2011) · Liver International · doi:10.1111/j.1478-3231.2010.02247.x · Cited by 152
Reporting of precision of estimates for diagnostic accuracy: a review
Harper, R. A., & Reeves, B. C. (1999) · BMJ · doi:10.1136/bmj.318.7194.1322 · Cited by 147
Furu, L., Onuchic², L. F., Gharavi, A. G., Hou, X., Esquivel, E. L., Nagasawa, Y., Bergmann, C., Senderek, J., Avner, E. D., Zerres, K., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000078805.87038.05 · Cited by 130
Neumann, H. P. H., Jilg, C. A., Bacher, J., Nabulsi, Z., Malinoc, A., Hummel, B., Hoffmann, M. M., Ortiz-Bruechle, N., Gläsker, S., Pisarski, P., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs551 · Cited by 110
The prevalence of DICER1 pathogenic variation in population databases
Kim, J., Field, A. P., Schultz, K. A. P., Hill, D. A., & Stewart, D. R. (2017) · International Journal of Cancer · doi:10.1002/ijc.30907 · Cited by 102
Mallawaarachchi, A. C., Hort, Y., Cowley, M. J., McCabe, M. J., Minoche, A. E., Dinger, M. E., Shine, J., & Furlong, T. J. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.48 · Cited by 98
Paterson, A. D., Magistroni, R., He, N., Wang, K., Johnson, A., Fain, P. R., Dicks, E. L., Parfrey, P. S., George‐Hyslop, P. S., & Pei, Y. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090758 · Cited by 96
Self-citationSolazzo, A., Testa, F., Giovanella, S., Busutti, M., Furci, L., Carrera, P., Ferrari, M., Ligabue, G., Mori, G., Leonelli, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190430 · Cited by 93
Trujillano, D., Bullich, G., Ossowski, S., Ballarín, J., Torrá, R., Estivill, X., & Ars, E. (2014) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.82 · Cited by 89
Adult polycystic liver and kidney diseases are separate entities
Karhunen, P. J., & Tenhu, M. (1986) · Clinical Genetics · doi:10.1111/j.1399-0004.1986.tb00565.x · Cited by 84
An Efficient and Comprehensive Strategy for Genetic Diagnostics of Polycystic Kidney Disease
Eisenberger, T., Decker, C., Hiersche, M., Hamann, R. C., Decker, E., Neuber, S., Frank, V., Bolz, H. J., Fehrenbach, H., Pape, L., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116680 · Cited by 82
de Andrade, K. C., Mirabello, L. J., Stewart, D. R., Karlins, E., Koster, R., Wang, M., Gapstur, S. M., Gaudet, M. M., Freedman, N. D., Landi, M. T., et al. (2017) · Human Mutation · doi:10.1002/humu.23320 · Cited by 70
Paterson, A. D., Wang, K. R., Lupea, D., George‐Hyslop, P. S., & Pei, Y. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.33908 · Cited by 48
Self-citationGall, É. C.-L., Chebib, F. T., Madsen, C. D., Senum, S. R., Heyer, C. M., Lanpher, B. C., Patterson, M. C., Albright, R. C., Yu, A. S. L., Torres, V. E., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.11.015 · Cited by 42
Self-citationMolecular diagnosis of autosomal dominant polycystic kidney disease
Song, X., Haghighi, A., Iliuta, I.-A., & Pei, Y. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1358088 · Cited by 33
Self-citationLarge deletions in the polycystic kidney disease 1 (PKD1) gene
Ariyürek, Y., Leeuwen, I. S. L., Spruit, L., Ravine, D., Breuning, M. H., & Peters, D. J. M. (2003) · Human Mutation · doi:10.1002/humu.9208 · Cited by 30
Center is an important indicator for choice of invasive therapy in polycystic liver disease
D‘Agnolo, H. M. A., Kievit, W., van Munster, K. N., van der Laan, J. J. H., Nevens, F., & Drenth, J. P. H. (2016) · Transplant International · doi:10.1111/tri.12875 · Cited by 18
Cited by
Bergmann, C., Guay-Woodford, L. M., Harris, P. C., Horie, S., Peters, D. J. M., & Torres, V. E. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0047-y · Cited by 807
Self-citationAutosomal dominant polycystic kidney disease
Cornec-Le Gall, E., Alam, A., & Perrone, R. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32782-x · Cited by 624
Metadata
- Authors
- Lanktree, M. B., Haghighi, A., Guiard, E., Iliuta, I.-A., Song, X., Harris, P. C., Paterson, A. D., & Pei, Y.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2018-08-22
- Volume
- 29
- Issue
- 10
- Pages
- 2593-2600
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- OpenAlex
- W2888346415
- Cited by
- 300
- References
- 41
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.